2008 UPDATES IN MMT
APRIL 2, 2008, OAKLAND
Alameda County Behavioral Health Sciences Building
2000 Embarcadero Cove, Oakland
(510)567-8100

Driving Directions

From South:
• Take I-880 traveling north.
• Exit at Embarcadero/5th Ave
• Proceed approx. 2/10 of a mile, bear to the left and go under I-880 North.
• At the stop sign, make a left onto Embarcadero.
• Follow Embarcadero approx. 1 mile to 2000 Embarcadero Cove.

From North:
• Take I-880 traveling south
• Exit at 16 Ave/Embarcadero
• Make a left onto Embarcadero ( Executive Inn will be on your right)
• Proceed approx. 1/4 mile to 2000 Embarcadero

PRESENTERS

• Joseph Graas, PhD - Founder/Partner & Laboratory Director, Advanced Scienti.c Systems Lab, San Diego Reference Laboratory
• David Kan, MD - Head of the Opioid Replacement Team, Veterans Administration Medical Center, San Francisco
• Judith Martin, MD - Medical Director, BAART Turk Street Clinic, San Francisco
• Elinore McCance-Katz, MD, PhD - Department of Psychiatry, UCSF
• Karen Miotto, MD - Medical Director, Substance Abuse Program, Los Angeles VA Ambulatory Care Center; Associate Professor, Department of Psychiatry and Behavioral Sciences, UCLA
• Diana Sylvestre, MD - Founder and Executive Director, OASIS, Oakland; Assistant Clinical Professor of Medicine, UCSF
• Matt Tierney, RN, NP, CNS - Nurse Practitioner III-Supervisor, San Francisco General Hospital, Department of Psychiatry, Division of Substance Abuse and Addiction Medicine
• Bonnie Wilford, MS - Director, Center for Health Services & Outcomes Research, JBS International, Inc.

PLANNERS

• David Kan, MD - Head of the Opioid Replacement Team, Veterans Administration Medical Center, San Francisco
• Karen Miotto, MD - Medical Director, Substance Abuse Program, Los Angeles VA Ambulatory Care Center; Associate Professor, Department of Psychiatry and Behavioral Sciences, UCLA
• Carolyn Schuman, MD - Medical Director of BAART 14th Street Clinic in Oakland and the San Mateo Medical Center Methadone Treatment Program
• Brad Shapiro, MD - Medical Director of the San Francisco Department of Public Health Opiate Treatment Outpatient Program (OTOP) and Office-Based Opiate Treatment Program (OBOT)

EDUCATIONAL OBJECTIVES
After participating in this program, registrants should be able to:

• Use safe dosage amounts in initial induction of a patient onto methadone
• Assess and quantify dependence on prescription opioids
• Manage and/or avoid non-therapeutic reactions between methadone and medications prescribed for HIV or other conditions
• Employ procedures that support and implement best practices and reduce the risk of legal action
• Make clinically helpful interpretations of lab reports of urine drug tests

SYLLABUS
The syllabus for this program includes the CSAM document, "Guideline for Physicians Working in California OTPs."

CREDIT
This is an activity sponsored by CSAM, a CMA-accredited provider. Physicians attending this program may report up to 6.5 AMA
PRA Category 1 Credits^TM. Physicians should only claim credit commensurate with the extent of their participation in the activity. The California Board of Registered Nursing recognizes Category 1 CME for RN license renewal purposes. Nurses may report Category 1 CME on a one-to-one basis. Write Category 1 CME in place of a provider number when reporting credits. For Physician Assistants, the American Academy of Physician Assistants and the NCCPA accept Category 1 Physician CME on a one-for-one basis.

CSAM gratefully acknowledges the educational grant from San Diego Reference Laboratories

SCHEDULE

8:00 am -- Registration (continental breakfast served)

8:30 -- Trends in the Epidemiology of Heroin and Prescription Opioid Use - Bonnie Wilford, MS

9:00 -- Safe Induction Technique: Initial Dose and Phases of Induction - Karen Miotto, MD

9:40 -- Case Discussion

9:55 -- Break

10:10 -- Cardiac Monitoring and the Risk of Prolonged QT interval / What Should We be Putting into Place and Doing in Our Clinic? - Judith Martin, MD

10:50 -- Methadone Interaction with HIV Medications - Elinore McCance-Katz MD, PhD

11:40 -- Case Discussion

11:55 -- Lunch

1:00 pm -- Hepatitis B/C in Methadone Patients / What OTPs Can/Should Do - Diana Sylvestre, MD

1:55 -- Methadone to Buprenorphine Transition - Matt Tierney, NP

2:25 -- MRO Perspective on New Methods - Hair and Saliva Testing Interpreting the Results of Urine Drug Screens - Joseph Graas, PhD

3:20 -- Break

3:35 -- Risk Management Elements that are Under the Control of the Physician: Balancing Risk Management with Good Treatment - David Kan, MD

4:30 -- Adjournment

Register Online